P3 Health Partners Business Summary

P3 Health Partners Inc. (PIII) operates as a patient-centered, physician-led population health management company primarily serving the Medicare Advantage market. The company’s revenue model is predominantly driven by capitated contracts, where it receives fixed monthly per-member payments from Medicare Advantage health plans to manage the total cost of care for its patient population. This "at-risk" model incentivizes clinical efficiency and preventative care over traditional volume-based metrics. Its primary business segments include its core Capitated revenue stream, which accounts for over 98% of total top-line results, and a secondary Fee-for-Service segment. Within the physician enablement and value-based care landscape, P3 positions itself as a middle-market MSO (Management Services Organization) that bridges the gap between independent providers and payers. It competes directly with larger players such as Agilon Health and Privia Health, as well as specialized competitors like EUDA Health, Marpai, and Centivo. The leadership team is currently led by Chief Executive Officer Dr. Aric Coffman, a physician executive who joined in May 2024 from Honest Medical Group and previously held senior roles at OptumCare and DaVita Medical Group. The company was co-founded in 2017 by Dr. Amir Bacchus, who serves as Chief Medical Officer, and former CEO Dr. Sherif Abdou, who remains a strategic advisor and board member. Other key executives include Chief Financial Officer Leif Pedersen, Chief Operating Officer Bill Bettermann, and Senior Vice President of Technology Devery Goodey. The board is chaired by Mark Thierer, the former CEO of Catamaran Corporation, bringing significant pharmacy benefit management and healthcare IT pedigree. P3 is backed by notable institutional investors including Chicago Pacific Founders (CPF), CRG, and Armistice Capital, reflecting a strong private equity and healthcare-focused capital structure.